AU601693B2 - Drug particles having constant release - Google Patents

Drug particles having constant release Download PDF

Info

Publication number
AU601693B2
AU601693B2 AU61190/86A AU6119086A AU601693B2 AU 601693 B2 AU601693 B2 AU 601693B2 AU 61190/86 A AU61190/86 A AU 61190/86A AU 6119086 A AU6119086 A AU 6119086A AU 601693 B2 AU601693 B2 AU 601693B2
Authority
AU
Australia
Prior art keywords
coating
drug particles
particles according
drug
inner coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU61190/86A
Other languages
English (en)
Other versions
AU6119086A (en
Inventor
Richard Edward Keim
Gary Robert Kelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU6119086A publication Critical patent/AU6119086A/en
Application granted granted Critical
Publication of AU601693B2 publication Critical patent/AU601693B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61190/86A 1985-08-16 1986-08-15 Drug particles having constant release Ceased AU601693B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76674585A 1985-08-16 1985-08-16
US766745 1985-08-16

Publications (2)

Publication Number Publication Date
AU6119086A AU6119086A (en) 1987-02-19
AU601693B2 true AU601693B2 (en) 1990-09-20

Family

ID=25077397

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61190/86A Ceased AU601693B2 (en) 1985-08-16 1986-08-15 Drug particles having constant release

Country Status (14)

Country Link
EP (1) EP0212745B1 (da)
JP (1) JPH0710772B2 (da)
AU (1) AU601693B2 (da)
CA (1) CA1275047A (da)
DE (1) DE3678641D1 (da)
DK (1) DK390386A (da)
GB (1) GB2180154B (da)
HK (1) HK126193A (da)
IE (1) IE59408B1 (da)
IL (1) IL79695A (da)
NZ (1) NZ217231A (da)
PH (1) PH23970A (da)
SG (1) SG59792G (da)
ZA (1) ZA866157B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
EP0212746B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
JP2687448B2 (ja) * 1988-06-22 1997-12-08 大正製薬株式会社 イブプロフェン徐放性製剤
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
DE19741114C2 (de) * 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische
WO2000044353A1 (de) 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
JP2007031281A (ja) * 2003-06-25 2007-02-08 Kowa Co イブプロフェン含有フィルムコーティング錠剤
CN102114011B (zh) * 2009-12-31 2012-12-12 北京科信必成医药科技发展有限公司 一种布洛芬缓释制剂及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3232684A (en) * 1983-08-24 1985-02-28 Bioresearch S.P.A. S-adenosyl-l-methionine salts preparation
AU6118986A (en) * 1985-08-16 1987-02-19 Procter & Gamble Company, The Drug particles having constant release and immediate release
AU6119186A (en) * 1985-08-16 1987-02-19 Procter & Gamble Company, The Drug particles having constant release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
EP0094123A3 (en) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Therapeutic granules
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3232684A (en) * 1983-08-24 1985-02-28 Bioresearch S.P.A. S-adenosyl-l-methionine salts preparation
AU6118986A (en) * 1985-08-16 1987-02-19 Procter & Gamble Company, The Drug particles having constant release and immediate release
AU6119186A (en) * 1985-08-16 1987-02-19 Procter & Gamble Company, The Drug particles having constant release

Also Published As

Publication number Publication date
DK390386A (da) 1987-02-17
AU6119086A (en) 1987-02-19
GB8619564D0 (en) 1986-09-24
GB2180154B (en) 1989-10-04
DK390386D0 (da) 1986-08-15
SG59792G (en) 1992-09-04
DE3678641D1 (de) 1991-05-16
JPH0710772B2 (ja) 1995-02-08
EP0212745B1 (en) 1991-04-10
IL79695A (en) 1990-09-17
IE862199L (en) 1987-02-16
ZA866157B (en) 1988-04-27
EP0212745A3 (en) 1987-11-11
HK126193A (en) 1993-11-26
IL79695A0 (en) 1986-11-30
NZ217231A (en) 1989-07-27
EP0212745A2 (en) 1987-03-04
CA1275047A (en) 1990-10-09
GB2180154A (en) 1987-03-25
JPS62111921A (ja) 1987-05-22
IE59408B1 (en) 1994-02-23
PH23970A (en) 1990-01-23

Similar Documents

Publication Publication Date Title
AU601692B2 (en) Drug particles having constant release and immediate release
AU601694B2 (en) Drug particles having constant release
AU601693B2 (en) Drug particles having constant release
CA1303504C (en) Pharmaceutical formulation containing acrivastine
EP0640337B1 (en) Controlled release-initiation and controlled release-rate pharmaceutical composition
CA1165246A (en) Slow release pharmaceutical composition
JP3806740B2 (ja) 薬剤運搬組成物
AU686168B2 (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
CA2016039C (en) Extended release pharmaceutical formulations
US7070806B2 (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
IE59200B1 (en) Therapeutic compositions for oral administration
AU736357B2 (en) Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
JPH01313431A (ja) ジルチアゼム・マイクロビーズ、その製法および徐放性医薬組成物
IE862201L (en) Drug particle